Skip to main content
. 2010 Jan 20;2010(1):CD000229. doi: 10.1002/14651858.CD000229.pub2

Morales 1988.

Methods Randomised clinical trial.
All women received betamethasone.
Participants 92 women at less than 33 weeks' gestation. Not eligible if intrauterine growth restriction, known congenital abnormalities, or maternal bleeding disorder.
Interventions 10 mg vitamin K intramuscularly every 5 days until delivery (n = 46). 
 Control group (n = 46) given no treatment.
Outcomes IVH assessed by cranial ultrasound 24 and 72 hours after birth reviewed by a radiologist blinded to treatment. Other neonatal morbidity including respiratory distress syndrome. 
 Cord blood clotting profiles.
Notes No sample size estimation reported. 
 All babies with any respiratory distress syndrome received mechanical ventilation.
Risk of bias
Bias Authors' judgement Support for judgement
Adequate sequence generation? Unclear risk Not reported by authors.
Allocation concealment? Unclear risk Allocation by sealed envelopes. Not reported if the envelopes were sequentially numbered or opaque.
Blinding? 
 All outcomes High risk No placebo used, however, assessment of the primary outcome was blinded.
Incomplete outcome data addressed? 
 All outcomes Unclear risk Losses to follow up not reported.
Free of selective reporting? Low risk No indication of selective reporting.
Free of other bias? Unclear risk Unclear.